A PERSONALISED APPROACH TO IVF
Adverse Event reporting information can be found in footer
Request a Meeting
Here you can find clinical and scientific resources along with Rekovelle® training materials.
Delivering personalised medicine through individualised dosing
SEE THE ALGORITHMEasy to follow instructions for your patients
SEE THE STEP-BY-STEP GUIDEWatch our video guide for using the Rekovelle® pen
WATCH THE VIDEOHow to work out your patient’s Rekovelle® dose in the first treatment cycle
CALCULATE THE DOSEUnderstand the mechanism of action of the algorithmic use of Rekovelle® for controlled ovarian stimulation
WATCH THE VIDEOInvestigating a personalised approach to assisted reproductive technology (ART) using recombinant follicle-stimulating hormone (rFSH) (follitropin delta) alongside the Elecsys® anti-müllerian hormone (AMH) assay
WHAT ARE THE ESTHER TRIALS?Individualised versus conventional ovarian stimulation for in vitro fertilisation (IVF)
LEARN MOREFollitropin delta in repeated ovarian stimulation for IVF: Phase 3 trial
LEARN MOREComparison of individualised dosing with follitropin delta vs conventional dosing with follitropin alfa in ovarian stimulation in Asian IVF/intracytoplasmic sperm injection (ICSI) patients
LEARN MOREComparison of individualised dosing with follitropin delta vs conventional dosing with follitropin beta in ovarian stimulation in Japanese women
LEARN MORELarge real-world study demonstrated Rekovelle® treatment patterns, ongoing pregnancy rates and safety consistent with randomised clinical trials
LEARN MOREJob Code: UK-REK-2300029 - Date of preparation: December 2023